KSHB: Recent Study Paves Way for Potential Multiple Sclerosis Vaccine

Over the last several decades, the number of people living with multiple sclerosis in the U.S. has more than doubled. Nearly one million Americans are living with the condition and about 200 new cases of MS are diagnosed each week.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life. Those who had the virus had a 32x higher risk of developing MS. Because of this study’s results, researchers are now working on developing a potential vaccine for multiple sclerosis in the future.

Dr. Rola Mahmoud, neurologist and director of Saint Luke’s Comprehensive Multiple Sclerosis Center, spoke with KSHB about the study. 

Related Content

Dec. 22, 2021

KSHB: Young Stroke Survivor Shares Story, Issues Warning
KSHB talked to Dr. Coleman Martin about why it is important to seek care quickly when experiencing any symptoms of a stroke.
Dec. 21, 2021

KMBC: Chillicothe pastor goes home in time for Christmas after recovering from paralyzing stroke
KMBC talked to Dr. Venessa Lee about Chuck Greever's inspiring recovery story.
Nov. 25, 2021

KSHB: 23-Year-Old Woman Survives Massive Brain Bleed Thanks to Saint Luke's Team
KSHB talked to Sophie Hardin and Dr. Andrew Schlachter, medical director of the Neurosciences ICU, about the young woman's incredible recovery.